460 related articles for article (PubMed ID: 22595154)
21. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence.
Détaint D; Lepage L; Himbert D; Brochet E; Messika-Zeitoun D; Iung B; Vahanian A
JACC Cardiovasc Interv; 2009 Sep; 2(9):821-7. PubMed ID: 19778769
[TBL] [Abstract][Full Text] [Related]
22. Sex differences in postprocedural aortic regurgitation and mid-term mortality after transcatheter aortic valve implantation.
Ferrante G; Pagnotta P; Petronio AS; Bedogni F; Brambilla N; Fiorina C; Giannini C; Mennuni M; De Marco F; Klugmann S; Ettori F; Presbitero P
Catheter Cardiovasc Interv; 2014 Aug; 84(2):264-71. PubMed ID: 24408011
[TBL] [Abstract][Full Text] [Related]
23. Dynamic characterization of aortic annulus geometry and morphology with multimodality imaging: predictive value for aortic regurgitation after transcatheter aortic valve replacement.
Masri A; Schoenhagen P; Svensson L; Kapadia SR; Griffin BP; Tuzcu EM; Desai MY
J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1847-54. PubMed ID: 23870156
[TBL] [Abstract][Full Text] [Related]
24. Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry.
Tateishi H; Campos CM; Abdelghani M; Leite RS; Mangione JA; Bary L; Soliman OI; Spitzer E; Perin MA; Onuma Y; Serruys PW; Lemos PA; Brito FS
EuroIntervention; 2016 Mar; 11(12):1409-18. PubMed ID: 26999681
[TBL] [Abstract][Full Text] [Related]
25. Transcatheter aortic valve implantation with the direct flow medical prosthesis: Impact of native aortic valve calcification degree on outcomes.
D'Ancona G; Agma HU; Ince H; El-Achkar G; Dißmann M; Ortak J; Kische S
Catheter Cardiovasc Interv; 2017 Jan; 89(1):135-142. PubMed ID: 27739165
[TBL] [Abstract][Full Text] [Related]
26. Abnormal distortion of aortic corevalve bioprosthesis with suicide left ventricle, aortic insufficiency, and severe mitral regurgitation during transcatheter aortic valve replacement.
Leya F; Tuchek JM; Coats W
Catheter Cardiovasc Interv; 2016 Dec; 88(7):1181-1187. PubMed ID: 26945836
[TBL] [Abstract][Full Text] [Related]
27. Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation.
Seiffert M; Bader R; Kappert U; Rastan A; Krapf S; Bleiziffer S; Hofmann S; Arnold M; Kallenbach K; Conradi L; Schlingloff F; Wilbring M; Schäfer U; Diemert P; Treede H
JACC Cardiovasc Interv; 2014 Oct; 7(10):1168-74. PubMed ID: 25129672
[TBL] [Abstract][Full Text] [Related]
28. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
[TBL] [Abstract][Full Text] [Related]
29. Transcatheter aortic valve implantation of a second-generation valve for pure aortic regurgitation: procedural outcome, haemodynamic data and follow-up.
Schlingloff F; Schäfer U; Frerker C; Schmoeckel M; Bader R
Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):388-93. PubMed ID: 24893871
[TBL] [Abstract][Full Text] [Related]
30. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
[TBL] [Abstract][Full Text] [Related]
31. Incidence, outcome and correlates of residual paravalvular aortic regurgitation after transcatheter aortic valve implantation and importance of haemodynamic assessment.
Patsalis PC; Konorza TF; Al-Rashid F; Plicht B; Riebisch M; Wendt D; Thielmann M; Jakob H; Eggebrecht H; Heusch G; Erbel R; Kahlert P
EuroIntervention; 2013 Apr; 8(12):1398-406. PubMed ID: 23256946
[TBL] [Abstract][Full Text] [Related]
32. Device landing zone calcification and its impact on residual regurgitation after transcatheter aortic valve implantation with different devices.
Seiffert M; Fujita B; Avanesov M; Lunau C; Schön G; Conradi L; Prashovikj E; Scholtz S; Börgermann J; Scholtz W; Schäfer U; Lund G; Ensminger S; Treede H
Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):576-84. PubMed ID: 26160399
[TBL] [Abstract][Full Text] [Related]
33. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
[TBL] [Abstract][Full Text] [Related]
34. Aortic regurgitation after transcatheter aortic valve implantation of the Edwards SAPIEN ™ valve.
Nielsen HH; Egeblad H; Andersen HR; Thuesen L; Poulsen SH; Klaaborg KE; Jakobsen CJ; Hjortdal VE
Scand Cardiovasc J Suppl; 2013 Feb; 47(1):36-41. PubMed ID: 22989057
[TBL] [Abstract][Full Text] [Related]
35. Clinical impact of paravalvular leaks on biomarkers and survival after transcatheter aortic valve implantation.
Schewel D; Frerker C; Schewel J; Wohlmuth P; Meincke F; Thielsen T; Kreidel F; Kuck KH; Schäfer U
Catheter Cardiovasc Interv; 2015 Feb; 85(3):502-14. PubMed ID: 24259366
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve.
Nombela-Franco L; Rodés-Cabau J; DeLarochellière R; Larose E; Doyle D; Villeneuve J; Bergeron S; Bernier M; Amat-Santos IJ; Mok M; Urena M; Rheault M; Dumesnil J; Côté M; Pibarot P; Dumont E
JACC Cardiovasc Interv; 2012 May; 5(5):499-512. PubMed ID: 22625188
[TBL] [Abstract][Full Text] [Related]
37. Quantitative assessment of paravalvular regurgitation following transcatheter aortic valve replacement.
Crouch G; Tully PJ; Bennetts J; Sinhal A; Bradbrook C; Penhall AL; De Pasquale CG; Baker RA; Selvanayagam JB
J Cardiovasc Magn Reson; 2015 May; 17(1):32. PubMed ID: 25953135
[TBL] [Abstract][Full Text] [Related]
38. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).
Hahn RT; Pibarot P; Webb J; Rodes-Cabau J; Herrmann HC; Williams M; Makkar R; Szeto WY; Main ML; Thourani VH; Tuzcu EM; Kapadia S; Akin J; McAndrew T; Xu K; Leon MB; Kodali SK
JACC Cardiovasc Interv; 2014 Jul; 7(7):781-9. PubMed ID: 25060022
[TBL] [Abstract][Full Text] [Related]
39. Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation.
Hayashida K; Lefèvre T
EuroIntervention; 2012 Sep; 8 Suppl Q():Q34-40. PubMed ID: 22995110
[TBL] [Abstract][Full Text] [Related]
40. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
